152 related articles for article (PubMed ID: 28715161)
21. Schedules of Controlled Substances: Placement of MT-45 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice.
Fed Regist; 2017 Dec; 82(238):58557-9. PubMed ID: 29235771
[TBL] [Abstract][Full Text] [Related]
22. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
Drug Enforcement Administration. Department of Justice
Fed Regist; 2013 Nov; 78(221):68716-9. PubMed ID: 24236337
[TBL] [Abstract][Full Text] [Related]
23. Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Apr; 81(72):22023-5. PubMed ID: 27101639
[TBL] [Abstract][Full Text] [Related]
24. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
[TBL] [Abstract][Full Text] [Related]
25. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
[TBL] [Abstract][Full Text] [Related]
26. Schedules of Controlled Substances: Placement of Three Synthetic Phenethylamines Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(187):66181-4. PubMed ID: 27726316
[TBL] [Abstract][Full Text] [Related]
27. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
[TBL] [Abstract][Full Text] [Related]
28. Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Mar; 82(39):12171-7. PubMed ID: 28355044
[TBL] [Abstract][Full Text] [Related]
29. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
[TBL] [Abstract][Full Text] [Related]
30. Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(218):69861-4. PubMed ID: 26567437
[TBL] [Abstract][Full Text] [Related]
31. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803
[TBL] [Abstract][Full Text] [Related]
32. Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II. Interim final rule with request for comments.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Aug; 81(166):58834-40. PubMed ID: 27568479
[TBL] [Abstract][Full Text] [Related]
33. Schedules of Controlled Substances: Placement of AB-CHMINACA, ABPINACA and THJ-2201 Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Oct; 82(198):47971-4. PubMed ID: 29035496
[TBL] [Abstract][Full Text] [Related]
34. Schedules of Controlled Substances: Extension of Temporary Placement of Three Synthetic Phenethylamines in Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(219):70657-9. PubMed ID: 26567439
[TBL] [Abstract][Full Text] [Related]
35. Schedules of Controlled Substances: Placement of UR-144, XLR11, and AKB48 into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 May; 81(91):29142-5. PubMed ID: 27192731
[TBL] [Abstract][Full Text] [Related]
36. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
[TBL] [Abstract][Full Text] [Related]
37. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
[TBL] [Abstract][Full Text] [Related]
38. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
39. Schedules of controlled substances: removal of naloxegol from control. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
[TBL] [Abstract][Full Text] [Related]
40. Schedules of Controlled Substances: Extension of Temporary Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA in Schedule I of the Controlled Substances Act. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Feb; 81(24):6175-7. PubMed ID: 26859904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]